Clinical conference: bacterial endocarditis.
D000293:Adolescent; D000667:Ampicillin / Q000627:therapeutic use; D002228:Carbenicillin / Q000627:therapeutic use; D002512:Cephalothin / Q000627:therapeutic use; D004359:Drug Therapy, Combination; D004697:Endocarditis, Bacterial / Q000175:diagnosis / Q000188:drug therapy / Q000209:etiology / Q000382:microbiology; D004917:Erythromycin / Q000627:therapeutic use; D005260:Female; D005839:Gentamicins / Q000627:therapeutic use; D006801:Humans; D008034:Lincomycin / Q000627:therapeutic use; D008712:Methicillin / Q000627:therapeutic use; D010068:Oxacillin / Q000627:therapeutic use; D010400:Penicillin G / Q000627:therapeutic use; D010406:Penicillins / Q000627:therapeutic use; D011008:Pneumococcal Infections / Q000150:complications; D011379:Prognosis; D011552:Pseudomonas Infections / Q000150:complications; D013203:Staphylococcal Infections / Q000150:complications; D013290:Streptococcal Infections / Q000150:complications; D013307:Streptomycin / Q000627:therapeutic use; D013449:Sulfonamides / Q000627:therapeutic use
D005839:Gentamicins; D010406:Penicillins; D013449:Sulfonamides; D004917:Erythromycin; D000667:Ampicillin; D008034:Lincomycin; D002228:Carbenicillin; D010400:Penicillin G; D008712:Methicillin; D002512:Cephalothin; D010068:Oxacillin; D013307:Streptomycin